Britain’s regulator on Thursday said modified coronavirus vaccines meant to target highly transmissible variants can sidestep new approvals and extended clinical trials.
Britain’s regulator on Thursday said modified coronavirus vaccines meant to target highly transmissible variants can sidestep new approvals and extended clinical trials.